What is the appropriate aspirin dosing regimen for a 70-year-old woman with non‑ST‑elevation myocardial infarction (NSTEMI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Aspirin Dosing in 70-Year-Old Woman with NSTEMI

Give non-enteric-coated, chewable aspirin 162-325 mg immediately as a loading dose, followed by a maintenance dose of 75-100 mg once daily indefinitely. 1, 2

Initial Loading Dose

  • Administer 162-325 mg of non-enteric-coated, chewable aspirin as soon as possible after presentation 2
  • The chewable formulation is critical because enteric-coated aspirin has delayed and reduced absorption, which is unacceptable in the acute setting 2
  • This loading dose should be given regardless of whether an invasive or ischemia-guided strategy is planned

Maintenance Dosing

The maintenance dose should be 75-100 mg once daily according to the most recent 2020 ESC guidelines 1. The 2014 AHA/ACC guidelines allow a broader range of 81-325 mg daily 2, but current evidence strongly supports the lower dose range.

Key Rationale for Lower Maintenance Dose:

  • High-dose aspirin (≥160 mg) increases bleeding risk without improving outcomes 2
  • In a 70-year-old woman, bleeding risk is particularly relevant as age ≥60 years is specifically identified as a risk factor for aspirin-related stomach bleeding 3
  • The ADAPTABLE trial (2024) confirmed that age does not modify aspirin's effectiveness, meaning 81 mg is as effective as 325 mg across all age groups including elderly patients 4

Special Considerations for Dual Antiplatelet Therapy

If using ticagrelor as the P2Y12 inhibitor (which is preferred over clopidogrel), the aspirin maintenance dose must be 81 mg daily 2. This is a critical dosing restriction specific to ticagrelor combination therapy.

Duration

  • Continue aspirin indefinitely as lifelong therapy 1, 2
  • Add a P2Y12 inhibitor (ticagrelor preferred, or clopidogrel/prasugrel) for up to 12 months 1, 2

Common Pitfalls to Avoid

  1. Do not use enteric-coated aspirin initially - it delays absorption when rapid platelet inhibition is needed 2
  2. Do not continue high-dose aspirin (325 mg) long-term - this unnecessarily increases bleeding risk in elderly patients without added benefit 2, 4
  3. Do not exceed 100 mg aspirin daily when using ticagrelor - higher doses reduce ticagrelor's efficacy 2
  4. Screen for contraindications including history of aspirin allergy, active bleeding, or severe bleeding risk 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.